As a potential competitor to Nvidia, Cerebras generated tremendous hype before its IPO.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
高シグナルの見出しのみ — マクロイベント、決算、M&A、規制。リスト記事とアナリストのクリックベイトはデフォルトでフィルタ。1時間ごとに更新。
As a potential competitor to Nvidia, Cerebras generated tremendous hype before its IPO.
Crypto exchange Gemini Space Station said on Thursday it has received a $100 million strategic investment from the family office of its founders, Cameron and Tyler Winklevoss. Winklevoss Capital Fund purchased Gemini’s Class A common stock at a price of $14 per share, with the payment made in bitcoin.
Investing.com -- Applied Materials reported record second-quarter revenue on Thursday and projected third-quarter revenue above Wall Street expectations, anticipating that robust investment in data centers and AI infrastructure will continue to drive demand for its chip-making equipment.
Gemini stock jumped 9% to $5.73 after Q1 2026 revenue rose 42% and Winklevoss Capital invested $100M in bitcoin.
The stock market hit highs as Nvidia led and AI chip IPO Cerebras soared in its debut, while Broadcom and Taiwan Semiconductor flashed buy signals. The Trump-Xi summit continues.
Is UPS a good stock to buy? We came across a bullish thesis on United Parcel Service, Inc. on r/StockPickNews by EaseQuiet529. In this article, we will summarize the bulls’ thesis on UPS. United Parcel Service, Inc.’s share was trading at $98.07 as of May 5th. UPS’s trailing and forward P/E were 15.58 and 13.46 respectively according […]
Is SONY a good stock to buy? We came across a bullish thesis on Sony Group Corporation on WinterGems: Industry Research’s Substack by @Govro12 WinterGems Stocks. In this article, we will summarize the bulls’ thesis on SONY. Sony Group Corporation’s share was trading at $20.73 as of May 6th. SONY’s trailing and forward P/E were 14.89 and […]
Is LEU a good stock to buy? We came across a bullish thesis on Centrus Energy Corp. on r/investing_discussion by Variant_Invest. In this article, we will summarize the bulls’ thesis on LEU. Centrus Energy Corp.’s share was trading at $231.32 as of May 6th. LEU’s trailing and forward P/E were 53.06 and 81.30 respectively according to Yahoo […]
Applied Materials' (AMAT) fiscal second-quarter results exceeded Wall Street's estimates as the semi
Applied Materials beat estimates for its fiscal Q2 and guided much higher than views for the current period. AMAT stock surged.
Rigetti shares tumbled despite its solid revenue growth.

US stocks (^DJI, ^IXIC, ^GSPC) close Thursday's session higher after the Dow Jones Industrial Average crossed back above 50,000 points on the winds of the latest AI rally. Yahoo Finance Senior Markets Reporter Ines Ferré highlights the leaders and biggest gainers in the semiconductor trade.
Both Big Tech stocks look like long-term winners, but one clearly has the upper hand.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the 10 Best Aggressive Growth Stocks to Buy According to Wall Street Analysts. On May 5, H.C. Wainwright reaffirmed its Buy rating on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) with a price target of $510 on the stock. This update came after the company reported Q1 results. The company reported […]
Amphenol Corporation (NYSE:APH) is one of the 10 Best Aggressive Growth Stocks to Buy According to Wall Street Analysts. On May 1, Seaport Research increased its price target on Amphenol Corporation (NYSE:APH) from $210 to $215 and maintained its Buy rating on the stock. This update comes after the company reported strong Q1 2026 results. […]
This actively managed ETF invests across U.S. and global equities, with a one-year price gain outpacing the S&P 500.
Major digital assets rose Thursday with Bitcoin (BTC-USD) topping $81,000. The CoinDesk Market In
As the physical layer of the AI revolution becomes the primary bottleneck of growth, IREN Limited has successfully re positioned itself from a crypto miner to a vital infrastructure provider.
Solar stocks are splitting on Thursday. Enphase Energy (NASDAQ:ENPH) is up 15% to $48.13 and SolarEdge Technologies (NASDAQ:SEDG) is up 17% to $50.04, while Canadian Solar (NASDAQ:CSIQ) is down 11% to $17.91. It’s a sharp rotation within the solar complex. Canadian Solar was the one-month leader heading into today, up 58% through Wednesday’s close, while ... SolarEdge Jumps 17%, Enphase Energy Leaps 15%, but Canadian Solar Sinks 11% in Lopsided Solar Stock Trade
PayPal has gotten torched over the last six months - since November 2025, its stock price has dropped 33% to $45.03 per share. This may have investors wondering how to approach the situation.
We recently published Jim Cramer Revealed His Big AI Investing Fear & Discussed These 20 Stocks. The Wendy’s Company (NASDAQ:WEN) is one of the stocks discussed by Jim Cramer. The Wendy’s Company (NASDAQ:WEN)’s shares were on Bank of America’s radar on April 24th as it reduced the share price target to $7 from $8 and […]
Low-cost retailer stock should be an obvious buy during stressful economic times, but the numbers aren’t matching the theory.
Cerebras Systems (CBRS) soared in its public market debut on Thursday after the artificial intellige
Buyers of new US homes gain a financial advantage during the first decade of ownership, compared wit
Nvidia stock is rallying on reports that the U.S. has approved H200 sales to 10 major Chinese customers. Recent filings also confirm that President Trump invested in NVDA shares in Q1.
Wondering whether Transocean at around US$6.62 is still offering value, or if most of the opportunity has already been priced in. The stock has delivered a 6.3% return over the last 7 days and is roughly flat over 30 days, while year to date it shows a 56.1% gain and 138.1% over the past year. This can change how investors think about both upside and risk. Recent coverage has focused on Transocean as an offshore drilling contractor in an energy sector that continues to attract attention,...
Despite fears of artificial intelligence (AI) disruption, this company is still seeing strong revenue and earnings growth.
Novo Nordisk and Biogen are underpriced and stand to gain from new indications for their blockbuster therapies.